Cairo – Mubasher: Arab Drug Company said Sunday that its ordinary general meeting (OGM) has approved the estimated budget and investment plan for fiscal year 2017/2018.
The company seeks to achieve an increase of 347.6% in profits for FY17/18 to EGP 18.8 million, and set the investment budget at EGP 57.6 million, according to a bourse filing.
Net profits for the current fiscal year was estimated at EGP 4.2 million.
The stock rose on Thursday by 1.21% to EGP 15.02.
